-transparent.png){kind=logo}
Enterocutaneous fistulas (ECFs) are a complex topic in terms of classification. ECF-related morbidity and mortality can be high due to fluid loss and electrolyte imbalance, sepsis, and malnutrition. Most prognostic factors influencing the outcome of ECF are now well-known. ECF treatment is complex; and, based on various situations, it can be surgical or conservative/ medical. Depending on fistula site and nutritional status, clinicians have to decide whether total parenteral or enteral nutrition should be established. In cases where total parenteral nutrition alone for 7 days has failed to influence the high output fistulas, overall data support the use of adjuvant drug, somatostatin, or its synthetic analogue, octreotide. Somatostatin 250 microg/d and octreotide 300-600 microg/d have been tried along with total parenteral nutrition to decrease the healing time of ECFs and to reduce the number of complications.
Z A Makhdoom, and
M J Komar, and
C D Still
November 1984,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
Z A Makhdoom, and
M J Komar, and
C D Still
June 1977,
North Carolina medical journal,
Z A Makhdoom, and
M J Komar, and
C D Still
February 1983,
Diseases of the colon and rectum,
Z A Makhdoom, and
M J Komar, and
C D Still
September 2010,
Clinics in colon and rectal surgery,
Z A Makhdoom, and
M J Komar, and
C D Still
June 1994,
Current problems in surgery,
Z A Makhdoom, and
M J Komar, and
C D Still
January 1965,
Revista argentina de cirugia,
Z A Makhdoom, and
M J Komar, and
C D Still
January 1983,
Zentralblatt fur Chirurgie,
Z A Makhdoom, and
M J Komar, and
C D Still
March 1982,
The British journal of surgery,
Z A Makhdoom, and
M J Komar, and
C D Still
June 2011,
The Surgical clinics of North America,
Z A Makhdoom, and
M J Komar, and
C D Still
June 2011,
European journal of trauma and emergency surgery : official publication of the European Trauma Society,
